Skip to NavigationSkip to content

Dr Kai Lindevall re-appointed chief executive of Encorium

Published on: 20/01/10

Dr Kai Lindevall has been re-appointed chief executive of contract research organisation (CRO) Encorium, having held the post in 2008 before becoming president of Encorium's Europe and Asia operations.

The last chief executive, David Ginsberg, left the firm last year to head up US division of Italian CRO Pierrel after it acquired Encorium’s US clinical trial operations.

Meanwhile, board member Shahab Fatheazam has also been named group chairman.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches